Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 21

Trial Status

Completed1
Recruiting2
Other1

Role Distribution

Other Roles4

Activity Timeline

Clinical Trials (4)

NCT07148050Phase 1Recruiting
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
Embryonal Sarcoma of LiverHepatoblastomaHepatocellular Carcinoma+7 more
StudydirectorStart date: 2025-12-22
NCT06465147Phase 1Recruiting
REACT-01: Reversing Autoimmunity Through Cell Therapy
Systemic Lupus Erythematosus
StudydirectorStart date: 2024-12-16

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Colleen Annesley, MD

Seattle Children's Hospital

Very Similar
7 trials

Shared therapeutic areas:

LeukemiaLymphomaEmbryonal Sarcoma of Liver+9 more

Worked with same sponsors:

Seattle Children's Hospital
Collaborated on 2 trials
Similarity Score128%

Shaun Jackson, MD

Seattle Children's Hospital

Related
1 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic

Worked with same sponsors:

Seattle Children's Hospital
Collaborated on 1 trial
Similarity Score14%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

LeukemiaLymphomaRhabdomyosarcoma+1 more
Similarity Score10%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

LeukemiaLymphomaRhabdomyosarcoma
Similarity Score8%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Carcinoma, HepatocellularLymphomaRhabdomyosarcoma
Similarity Score8%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphoma
Similarity Score5%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphoma
Similarity Score5%

Anjali Advani, MD

The Cleveland Clinic

Related
7 trials

Shared therapeutic areas:

LeukemiaLymphoma
Similarity Score5%

Meir Wetzler, MD

Roswell Park Cancer Institute

Related
5 trials

Shared therapeutic areas:

LeukemiaLymphoma
Similarity Score5%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

LymphomaLeukemia
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT07148050Phase 1StudyDirector

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Embryonal Sarcoma of LiverHepatoblastomaHepatocellular Carcinoma+7 more
Recruiting
NCT06465147Phase 1StudyDirector

REACT-01: Reversing Autoimmunity Through Cell Therapy

Systemic Lupus Erythematosus
Recruiting
NCT04571138Phase 1/2StudyChair

A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma

LeukemiaLymphoma
Active Not Recruiting
NCT03244306Phase 1StudyChair

A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma

Leukemia
Completed

All 4 trials loaded